Hospital policies for treatment of acute decompensated heart failure

被引:2
作者
Vats, Vikrant
DiDomenico, Robert J.
Wojtynek, Jeffrey E.
Theobald, John C.
Schumock, Glen T.
机构
[1] Univ Illinois, Coll Pharm, Dept Pharm Practice, Ctr Pharmacoecon Res, Chicago, IL 60612 USA
[2] Consorta Inc, Clin Contracting Pharm Integrat, Schaumburg, IL USA
[3] Consorta Inc, Clin Pharm Serv, Schaumburg, IL USA
关键词
acute decompensated heart failure; diuretics; guidelines; nesiritide;
D O I
10.1345/aph.1H664
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: It is unclear to what extent hospitals use guidelines or protocols in treating acute decompensated heart failure (ADHF) and whether nesiritide is included in these guidelines or protocols. OBJECTIVE: To assess the formulary status of currently used drugs, therapeutic guidelines, and perceptions about the appropriateness of treatment of ADHF in community hospitals. METHODS: A Web-based survey of pharmacy directors at community hospitals that were part of a national group purchasing organization was conducted. RESULTS: One hundred seven hospitals participated in the survey (response rate 47.1%). Diuretics such as furosemide and bumetanide were more commonly included (100% and 94.4%, respectively) on hospital formularies than was torsemide (69.2%). Dopamine and dobutamine were more common (94.4% each) on the formulary than was milrinone (68.2%). Nitroprusside and nitroglycerin were listed on the formularies of more than 90% of participating institutions, while nesiritide was listed on the formularies in only 48.6% of hospitals and was placed on restricted status in 36.4% of hospitals. Guidelines for care of patients with ADHF were used in the emergency department (ED), inpatient care units, and outpatient clinics in 18.6%, 43.0%, and 8.5% of hospitals, respectively. Overall, ADHF care, including general treatment as well as specific use of nesiritide, was deemed appropriate in the majority of patients, but nearly twice as many respondents perceived the management of ADHF and specific use of nesiritide as inappropriate in the ED compared with inpatient treatment. Only 41.1% of the respondents reported following Braunwald recommendations for the use of nesiritide. CONCLUSIONS: A sizable percentage of responding community hospitals do not have guidelines for treatment of ADHF despite the existence of such guidelines in the literature. There are opportunities for improvement in the general treatment of ADHF as well as for the use of nesiritide in ADHF, especially in the ED or observation unit versus inpatient units.
引用
收藏
页码:562 / 567
页数:6
相关论文
共 16 条
[1]   Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000, cases in the Acute Decompensated Heart Failure National Registry (ADHERE) [J].
Adams, KF ;
Fonarow, GC ;
Emerman, CL ;
LeJemtel, TH ;
Costanzo, MR ;
Abraham, WT ;
Berkowitz, RL ;
Galvao, M ;
Horton, DP .
AMERICAN HEART JOURNAL, 2005, 149 (02) :209-216
[2]  
Aghababian Richard V, 2002, Rev Cardiovasc Med, V3 Suppl 4, pS3
[3]  
*AM HOSP ASS GUID, 2006, HLTH FOR AHA
[4]   Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: The PRECEDENT study [J].
Burger, AJ ;
Horton, DP ;
LeJemtel, T ;
Ghali, JK ;
Torre, G ;
Dennish, G ;
Koren, M ;
Dinerman, J ;
Silver, M ;
Cheng, ML ;
Elkayam, U .
AMERICAN HEART JOURNAL, 2002, 144 (06) :1102-1108
[5]   Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. [J].
Colucci, WS ;
Elkayam, U ;
Horton, DP ;
Abraham, WT ;
Bourge, RC ;
Johnson, AD ;
Wagoner, LE ;
Givertz, MM ;
Liang, CS ;
Neibaur, M ;
Haught, WH .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (04) :246-253
[6]   Guidelines for acute decompensated heart failure treatment [J].
DiDomenico, RJ ;
Park, HY ;
Southworth, MR ;
Eyrich, HM ;
Lewis, RK ;
Finley, JM ;
Schumock, GT .
ANNALS OF PHARMACOTHERAPY, 2004, 38 (04) :649-660
[7]  
Eyrich HM, 2005, PHARMACOTHERAPY, V25, P1435
[8]   Risk stratification for in-hospital mortality in acutely decompensated heart failure - Classification and regression tree analysis [J].
Fonarow, GC ;
Adams, KF ;
Abraham, WT ;
Yancy, CW ;
Boscardin, WJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (05) :572-580
[9]  
Heart Failure Society Of America, 2006, J Card Fail, V12, pe1
[10]   Readmission after hospitalization for congestive heart failure among Medicare beneficiaries [J].
Krumholz, HM ;
Parent, EM ;
Tu, N ;
Vaccarino, V ;
Wang, Y ;
Radford, MJ ;
Hennen, J .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (01) :99-104